Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Frontiers in Medicine|June 23, 2022
Top 100 Cited Articles on Clinical Hematopoietic Stem Cell Transplantation: A Bibliometric AnalysisMoazzam Shahzad, Sibgha Gull Chaudhary, Iqra Anwar, et al.Transplant Immunology|October 5, 2024
Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic reviewMoazzam Shahzad, Muhammad Atif Khan, Muhammad Kashif Amin, et al.Clinical Lymphoma, Myeloma & Leukemia|May 21, 2026
Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age GroupMuhammad Umair Mushtaq, Muhammad Kashif Amin, Amir Kasaeian, et al.Clinical Lymphoma, Myeloma & Leukemia|January 31, 2025
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-AnalysisMoazzam Shahzad, Muhammad Kashif Amin, Muhammad Fareed Khalid, et al.Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid LeukemiaMoazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, et al.Clinical Lymphoma, Myeloma & Leukemia|September 17, 2025
Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World ExperienceAnas Zayad, Gray Magee, Razan Mansour, et al.Transplantation and Cellular Therapy|May 13, 2026
Long-Term Gynecologic and Reproductive Health in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of PrevalenceMuhammad Kashif Amin, Nabeeha Noor, Muhammad Talha Maqsood, et al.Bone Marrow Transplantation|May 5, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelinesAqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad, et al.European Journal of Haematology|January 16, 2026
Comparative Efficacy of Daratumumab Based Regimens in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) Aged 70 and Above: A Multicenter StudyRazan Mansour, Kimberly M Green, Chandler Graf, et al.Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With MyelofibrosisMoazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, et al.Pageof 8